Nj State Employees Deferred Compensation Plan Ligand Pharmaceuticals Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 5,000 shares of LGND stock, worth $593,200. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$593,200
Previous $421,000
18.76%
% of portfolio
0.06%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding LGND
# of Institutions
257Shares Held
17.9MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$341 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$234 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$120 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$105 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$83.9 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...